FDA Panel Backs Gilead Sciences' Hepatitis C Drug

Published October 31, 2013

FDA panel backs Gilead Sciences' hepatitis C drug
For most of the last 20 years, the standard treatment for hepatitis C has involved a grueling one-year regimen of pills and injections that causes flu-like symptoms and cures fewer than half of patients. Then in 2011, the FDA approved two new drugs …
Read more on San Jose Mercury News

Los Gatos: New cookbook by award-winning Kinch is a 'Reflection' of Manresa
Kinch also profiles those who have made key contributions to his operation, and introduces readers to Santa Cruz Mountains wines via notes from San Francisco Chronicle wine editor Jon Bonné. Look for … Now the facility has extended its range of …
Read more on San Jose Mercury News

Related Drug Alcohol Rehab Center San Jose Information…